$AMGN Headlines FDA panel recommends approval for first

New Post Public Reply Private Reply Replies (0) Message Board

Jan 23, 2015 at 11:54 AM

$AMGN Headlines

FDA panel recommends approval for first generic biotech drug 4:51 p.m. Jan. 7, 2015 - Wallace Witkowski
Novartis wins FDA staff Ok for Neupogen generic 12:46 p.m. Jan. 5, 2015 - Marta Falconi
Amgen and Kite Pharma in cancer immunotherapy pact 10:00 a.m. Jan. 5, 2015 - Tess Stynes
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Amgen boosts first-quarter dividend 30% to 79 cents a share 5:46 p.m. Dec. 17, 2014 - Tom Bemis
Amgen ends trials of stomach-cancer therapy 9:57 a.m. Nov. 24, 2014 - Tess Stynes
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen's stock drops 2% in premarket trade 9:07 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen study on cancer treatment misses secondary endpoint 9:06 a.m. Nov. 4, 2014 - Tomi Kilgore
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn

What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Today - Seeking Alpha
New Guru Jana Partners' Newest Stock Buys 8:05 p.m. Jan. 22, 2015 - GuruFocus.com
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog 7:00 p.m. Jan. 22, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog 6:00 p.m. Jan. 22, 2015 - Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog 5:40 p.m. Jan. 22, 2015 - Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog 4:10 p.m. Jan. 22, 2015 - Zacks.com
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog 6:13 p.m. Jan. 21, 2015 - Zacks.com
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog 6:08 p.m. Jan. 21, 2015 - Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog 5:00 p.m. Jan. 21, 2015 - Zacks.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog 12:50 p.m. Jan. 21, 2015 - Zacks.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog 11:02 a.m. Jan. 21, 2015 - Zacks.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog 6:03 p.m. Jan. 20, 2015 - Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog 5:00 p.m. Jan. 20, 2015 - Zacks.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog 3:30 p.m. Jan. 20, 2015 - Zacks.com
AZN, ABT And AMGN, 3 Drugs Stocks Pushing The Industry Lower 12:20 p.m. Jan. 20, 2015 - TheStreet.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog 11:55 a.m. Jan. 20, 2015 - Zacks.com
Find Your Dividend Yield Sweet Spot 10:11 a.m. Jan. 20, 2015 - Seeking Alpha
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog 6:35 p.m. Jan. 19, 2015 - Zacks.com

Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 4:01 p.m. Jan. 22, 2015 - PR Newswire - PRF
Technology Industry Leaders to Join Gala Global, Inc. Board of Directors 8:01 a.m. Jan. 21, 2015 - GlobeNewswire
Global Cancer Biomarkers Market 2015-2019 1:24 p.m. Jan. 20, 2015 - PR Newswire - PRF
Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer 4:01 p.m. Jan. 15, 2015 - PR Newswire - PRF
Global Ankylosing Spondylitis Market 2015-2019 4:16 p.m. Jan. 14, 2015 - PR Newswire - PRF
NantWorks Announces Launch of an Immuno-Oncology Company, NantCell, and Licensing Agreement with Amgen for an Oncology Antibody 8:01 a.m. Jan. 14, 2015 - BusinessWire - BZX
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome 4:01 p.m. Jan. 12, 2015 - PR Newswire - PRF
Hospira Submits New Biologics License Application to U.S. FDA for Proposed Epoetin Alfa Biosimilar 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 8, 2015 - PR Newswire - PRF
Surface Oncology Announces $35 Million Series A Financing to Advance Next-Generation Cancer Immunotherapies 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies 9:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma 8:35 a.m. Dec. 31, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts 9:15 a.m. Dec. 22, 2014 - PR Newswire - PRF
Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience 7:00 a.m. Dec. 22, 2014 - GlobeNewswire
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend 5:45 p.m. Dec. 17, 2014 - PR Newswire - PRF
Apotex Announces FDA Has Accepted For Filing its Biosimilar Application for Pegfilgrastim 10:23 a.m. Dec. 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...